Hepatitis C treatment among racial and ethnic groups in the IDEAL trial (English)
- New search for: Muir, A. J.
- New search for: Hu, K. ‐Q.
- New search for: Gordon, S. C.
- New search for: Koury, K.
- New search for: Boparai, N.
- New search for: Noviello, S.
- New search for: Albrecht, J. K.
- New search for: Sulkowski, M. S.
- New search for: McCone, J.
- New search for: Muir, A. J.
- New search for: Hu, K. ‐Q.
- New search for: Gordon, S. C.
- New search for: Koury, K.
- New search for: Boparai, N.
- New search for: Noviello, S.
- New search for: Albrecht, J. K.
- New search for: Sulkowski, M. S.
- New search for: McCone, J.
In:
Journal of Viral Hepatitis
;
18
, 4
;
e134-e143
;
2011
- Article (Journal) / Electronic Resource
-
Title:Hepatitis C treatment among racial and ethnic groups in the IDEAL trial
-
Contributors:Muir, A. J. ( author ) / Hu, K. ‐Q. ( author ) / Gordon, S. C. ( author ) / Koury, K. ( author ) / Boparai, N. ( author ) / Noviello, S. ( author ) / Albrecht, J. K. ( author ) / Sulkowski, M. S. ( author ) / McCone, J. ( author )
-
Published in:Journal of Viral Hepatitis ; 18, 4 ; e134-e143
-
Publisher:
- New search for: Blackwell Publishing Ltd
-
Publication date:2011-04-01
-
Size:10 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 18, Issue 4
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 229
-
Hepatitis C virus infection during pregnancy and the newborn period – are they opportunities for treatment?Arshad, M. / El‐Kamary, S. S. / Jhaveri, R. et al. | 2011
- 237
-
Total and cause‐specific mortality rates in a prospective study of community‐acquired hepatitis C virus infection in northern NorwayKristiansen, M. G. / Løchen, M. ‐L. / Gutteberg, T. J. / Mortensen, L. / Eriksen, B. O. / Florholmen, J. et al. | 2011
- 245
-
Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infectionPedersen, C. / Alsiö, Å. / Lagging, M. / Langeland, N. / Färkkilä, M. / Rauning Buhl, M. / Mørch, K. / Westin, J. / Sangfelt, P. / Norkrans, G. et al. | 2011
- 252
-
Quality of life in patients with various liver diseasesTillmann, H. L. / Wiese, M. / Braun, Y. / Wiegand, J. / Tenckhoff, S. / Mössner, J. / Manns, M. P. / Weissenborn, K. et al. | 2011
- 262
-
Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spotsHope, V. D. / Hickman, M. / Ngui, S. L. / Jones, S. / Telfer, M. / Bizzarri, M. / Ncube, F. / Parry, J. V. et al. | 2011
- 271
-
Controlled release recombinant human interferon‐α2b for treating patients with chronic hepatitis C genotype 1: a phase 2a clinical trialDzyublyk, I. / Yegorova, T. / Moroz, L. / Popovych, O. / Zaytsev, I. / Miroshnichenko, V. / Kromminga, A. / Wilkes, M. M. / van Hoogdalem, E. J. / Humphries, J. E. et al. | 2011
- 280
-
Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated‐interferon‐alpha 2b and ribavirin combination therapyHayashi, K. / Katano, Y. / Ishigami, M. / Itoh, A. / Hirooka, Y. / Nakano, I. / Urano, F. / Yoshioka, K. / Toyoda, H. / Kumada, T. et al. | 2011
- 287
-
Virologic and biochemical responses to clevudine in patients with chronic HBV infection‐ associated cirrhosis: data at week 48Kim, J. H. / Yim, H. J. / Jung, E. S. / Jung, Y. K. / Seo, Y. S. / Yeon, J. E. / Lee, H. S. / Um, S. H. / Byun, K. S. et al. | 2011
- 294
-
Clinical, epidemiological characteristics and indications for liver biopsy and treatment in immigrants with chronic hepatitis B at a referral hospital in MadridPérez‐Molina, J. A. / Herrero‐Martínez, J. M. / Norman, F. / Pérez‐Ayala, A. / Monge‐Mahillo, B. / Navarro‐Beltrá, M. / López‐Vélez, R. et al. | 2011
- 300
-
Single‐step real‐time PCR to quantify hepatitis B virus and distinguish genotype D from non‐D genotypesAmini‐Bavil‐Olyaee, S. / Pourkarim, M. R. / Schaefer, S. / Mahboudi, F. / Van Ranst, M. / Adeli, A. / Trautwein, C. / Tacke, F. et al. | 2011
- e1
-
Hepatitis A outbreaks: the effect of a mass vaccination programmeTorner, N. / Broner, S. / Martinez, A. / Godoy, P. / Batalla, J. / Dominguez, A. / the Hepatitis A Surveillance Group of Catalonia et al. | 2011
- e5
-
Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteersDe Schryver, A. / Verstrepen, K. / Vandersmissen, L. / Vandermeeren, N. / Vernaillen, I. / Vranckx, R. / Van Damme, P. / van Sprundel, M. et al. | 2011
- e11
-
Distinct geographical and demographic distribution of hepatitis B virus genotypes in the Canadian Arctic as revealed through an extensive molecular epidemiological surveyOsiowy, C. / Larke, B. / Giles, E. et al. | 2011
- e20
-
An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringesArankalle, V. A. / Gandhi, S. / Lole, K. S. / Chadha, M. S. / Gupte, G. M. / Lokhande, M. U. et al. | 2011
- e29
-
Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue‐experienced Chinese patients with chronic HBV infectionLiu, Y. / Wang, C. / Zhong, Y. / Li, X. / Dai, J. / Ren, X. / Xu, Z. / Li, L. / Yao, Z. / Ji, D. et al. | 2011
- e40
-
Hepatitis B in the Greater San Francisco Bay Area: an integrated programme to respond to a diverse local epidemicGish, R.G. / Cooper, S.L. et al. | 2011
- e52
-
Very early prediction of response to HCV treatment with PEG‐IFN‐alfa‐2a and ribavirin in HIV/HCV‐coinfected patientsAraújo, E. S. A. / Dahari, H. / Neumann, A. U. / de Paula Cavalheiro, N. / Melo, C. E. / de Melo, E. S. / Layden, T. J. / Cotler, S. J. / Barone, A. A. et al. | 2011
- e61
-
Uptake of hepatitis C antibody testing in patients with end‐stage liver disease in Glasgow, 1993–2007McDonald, S. A. / Hutchinson, S. J. / Cameron, S. / Bird, S. M. / Mills, P. R. / McLeod, A. / Goldberg, D. J. et al. | 2011
- e66
-
Interleukin‐28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV‐1‐infected cohortClausen, L. N. / Weis, N. / Astvad, K. / Schønning, K. / Fenger, M. / Krarup, H. / Bukh, J. / Benfield, T. et al. | 2011
- e75
-
The optimal cut‐off for predicting large oesophageal varices using transient elastography is disease specificPritchett, S. / Cardenas, A. / Manning, D. / Curry, M. / Afdhal, N. H. et al. | 2011
- e81
-
Estimating the likelihood of sustained virological response in chronic hepatitis C therapyMauss, S. / Hueppe, D. / John, C. / Goelz, J / Heyne, R. / Moeller, B. / Link, R. / Teuber, G. / Herrmann, A. / Spelter, M. et al. | 2011
- e91
-
The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis CVigani, A. G. / Macedo de Oliveira, A. / Tozzo, R. / Pavan, M. H. P. / Gonçales, E. S. / Fais, V. / Gonçales, N. S. / Gonçales, F. L. et al. | 2011
- e99
-
Extended treatment duration for treatment naïve chronic hepatitis C genotype 1 late viral responders: a meta‐analysis comparing 48 weeks vs 72 weeks of pegylated interferon and ribavirinParikh, M. / Singh, A. / Sood, G. et al. | 2011
- e104
-
Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, AustraliaGrebely, J. / Bryant, J. / Hull, P. / Hopwood, M. / Lavis, Y. / Dore, G. J. / Treloar, C. et al. | 2011
- e117
-
Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapyKumthip, K. / Pantip, C. / Chusri, P. / Thongsawat, S. / O’Brien, A. / Nelson, K. E. / Maneekarn, N. et al. | 2011
- e126
-
The influence of hepatitis C and alcohol on liver‐related morbidity and mortality in Glasgow’s injecting drug user populationMcDonald, S. A. / Hutchinson, S. J. / Mills, P. R. / Bird, S. M. / Cameron, S. / Dillon, J. F. / Goldberg, D. J. et al. | 2011
- e134
-
Hepatitis C treatment among racial and ethnic groups in the IDEAL trialMuir, A. J. / Hu, K. ‐Q. / Gordon, S. C. / Koury, K. / Boparai, N. / Noviello, S. / Albrecht, J. K. / Sulkowski, M. S. / McCone, J. et al. | 2011
- e144
-
Serum lipids and their associations with viral levels and liver disease severity in a treatment‐naïve chronic hepatitis C type 1‐infected cohortRamcharran, D. / Wahed, A. S. / Conjeevaram, H. S. / Evans, R. W. / Wang, T. / Belle, S. H. / Yee, L. J. et al. | 2011
- e153
-
GB virus C infection among young, HIV‐negative injection drug users with and without hepatitis C virus infectionBoodram, B. / Hershow, R. C. / Klinzman, D. / Stapleton, J. T. et al. | 2011
- e160
-
Quantification of viral DNA and liver enzymes in plasma improves early diagnosis and management of herpes simplex virus hepatitisBeersma, M. F. C. / Verjans, G. M. G. M. / Metselaar, H. J. / Osterhaus, A. D. M. E. / Berrington, W. R. / van Doornum, G. J. et al. | 2011